Overview


According to FutureWise analysis, the market for Adult and Pediatric Hemoconcentrators is expected to reach US$ 16.49 billion by 2031 at a CAGR of 3.2% over the forecast period of 2023-2031.

Hemoconcentrators are referred to as an increased level of concentration of blood cells, resulting in the loss of plasma or water from the bloodstream. At the same time, it preserves essential components of blood, such as blood cells, albumin, and other valuable molecules with higher molecular weights. These devices help maintain the proper hematocrit levels, which are essential for the patient's well-being. Increased levels of hematocrit and hemoglobin have been identified as a risk factor for developing various diseases, including stroke, coronary heart disease, hypertension, and several other health conditions. Additionally, a growing body of evidence indicates increased hematocrit and hemoglobin levels can be observed in physical and mental stressors.

The HEMOCOR HPH hemoconcentrator family of high-performance hemoconcentrators is designed to satisfy the needs of both adult and pediatric patients. The high performance of the HEMOCOR HPH hemoconcentrator allows the perfusionist to manage the patient's hematocrit and fluid level. The convenience of the "no-rinse" hemoconcentrator allows insertion into the extracorporeal circuit at any time during surgery without the need to rinse the unit. HEMOCOR HPH hemoconcentrators are developed using glycerine-free polysulfone membranes. Such membranes have exceptional biocompatibility through a broad range of medical device applications.

FutureWise Market Research has published a report that provides an insightful adult and pediatric hemoconcentrators market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, adult and pediatric hemoconcentrators market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medivators Inc.
  • Terumo Corporation
  • LivaNova, PLC
  • Maquet (a Getinge Group company)
  • Medica S.p.A

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Adult and Pediatric Hemoconcentrators Market:

  • In February 2021, the Government of Maharashtra, India, launched the ST-Elevation Myocardial Infarction (STEMI) Maharashtra program that uses Artificial Intelligence (AI) to allow rapid diagnosis of various heart conditions and reduce the mortality rate associated with them.

The increasing prevalence of cardiovascular diseases, including complex cardiovascular surgeries like open-heart and bypass procedures, is expected to drive the growth of the adult and pediatric hemoconcentrators market. These medical devices are essential in maintaining optimal blood volume and fluid balance during surgeries, improving patient outcomes. Additionally, the growing awareness among healthcare institutions and professionals regarding the importance of blood conservation and reducing blood transfusions whenever feasible drives the adoption of hemoconcentrators. These devices allow the concentration and reinfusion of a patient's blood, with a growing focus on patient safety and cost-effectiveness in healthcare. Furthermore, the requirement of technical expertise and specialization to operate these medical devices effectively is expected to be a significant impediment to market growth. Ensuring staff members are well-trained and qualified to use hemoconcentrators might be resource-intensive and time-consuming for healthcare institutions. This challenge may hinder the seamless integration of hemoconcentrators into clinical settings, potentially limiting their use of medical procedures. Moreover, alternative technologies or treatment procedures, such as dialysis machines or other blood purification methods, create competition among key players to develop novel medical devices and are expected to restrain the growth of the adult and pediatric hemoconcentrators market. These alternatives have proven track records and more comprehensive applications in healthcare, which may cause healthcare providers to be reluctant to switch to hemoconcentrators.

By Product Type

  • Adult Hemoconcentrators
  • Pediatric Hemoconcentrators

By End User

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the growing public awareness of advanced technology for blood component transfusion, high prevalence of cardiovascular diseases, growing aging population, well-established healthcare infrastructure, favourable reimbursement situations, and increase in cell-based research activities are expected to drive the demand for adult and pediatric hemoconcentrators market over the projection period. Furthermore, since heart failure is the leading cause of death in the U.S., hemoconcentrators are available in various sizes to reduce cardiac bypass surgery, allowing for market expansion. For instance, as per the data published by the American Heart Association, approximately 92.1 million adults in the United States suffer from various forms of cardiovascular disease or the after-effects of stroke. Cardiovascular diseases, listed as the primary cause of death, account for about 836,546 deaths in the U.S. Therefore, it is expected to propel the growth of the market during the forecast period in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Adult and Pediatric Hemoconcentrators Market By Product Type, By Formulation, By Application and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Adult and Pediatric Hemoconcentrators Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adult and Pediatric Hemoconcentrators Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Adult and Pediatric Hemoconcentrators Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Adult and Pediatric Hemoconcentrators Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Adult Hemoconcentrators
        2. Pediatric Hemoconcentrators

  • 8.   Adult and Pediatric Hemoconcentrators Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital
        2. Ambulatory Surgical Centers
        3. Others

  • 9.   North America Adult and Pediatric Hemoconcentrators Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Adult and Pediatric Hemoconcentrators Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Adult and Pediatric Hemoconcentrators Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Adult and Pediatric Hemoconcentrators Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Adult and Pediatric Hemoconcentrators Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medivators Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Terumo Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. LivaNova, PLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Maquet (a Getinge Group company)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Medica S.p.A
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients